Treace Medical Concepts
TMCI
137 hedge funds and large institutions have $996M invested in Treace Medical Concepts in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 64 increasing their positions, 35 reducing their positions, and 12 closing their positions.
485% more call options, than puts
Call options by funds: $3.03M | Put options by funds: $519K
117% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 12
83% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 35
11% more funds holding
Funds holding: 123 → 137 (+14)
11% more capital invested
Capital invested by funds: $895M → $996M (+$101M)
5.39% more ownership
Funds ownership: 58.1% → 63.49% (+5.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.5M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$18.7M |
| 3 |
BlackRock
New York
|
+$13.6M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.95M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$12.9M |
| 2 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$9.38M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$7.13M |
| 4 |
PA
Perceptive Advisors
New York
|
-$5.81M |
| 5 |
Millennium Management
New York
|
-$4.92M |
TMCI Hedge Fund Activity: Q2 2023 in Review
137 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q2 2023, worth a combined $996M — up 11% from $895M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new TMCI positions and 12 closed out — a net gain of 14 holders — while 64 added to existing stakes and 35 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $27.5M. The largest seller was Citadel Advisors, cutting an estimated $12.9M.
- 137 institutional investors held Treace Medical Concepts (TMCI) as of Q2 2023, up from 123 in Q1 2023.
- Funds reported $996M of Treace Medical Concepts stock for Q2 2023, up 11% quarter-over-quarter.
- 26 funds opened new Treace Medical Concepts positions in Q2 2023 and 12 closed out, a net change of +14 holders.
- The largest Treace Medical Concepts buyer in Q2 2023 was Point72 Asset Management, an estimated $27.5M added.
- The largest Treace Medical Concepts seller in Q2 2023 was Citadel Advisors, an estimated $12.9M sold.
Based on aggregated 13F filings for Q2 2023.